Clinical trial
Spinraza (Nusinersen) SMA Pregnancy Exposure Study Within Existing SMA Registries
NCT05789758 is registered in ClinicalTrials.gov with Biogen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Spinraza (Nusinersen) SMA Pregnancy Exposure Study Within Existing SMA Registries
- Lead sponsor
- Biogen
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- December 15, 2023
- Completion date
- October 31, 2033
- Enrollment
- 20 (estimated)
- Sites
- 14
Conditions
As the registry lists them; a condition with its own page is linked.